Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sleep Apnea, Obstructive | 147 | 2024 | 1897 | 11.540 |
Why?
|
Continuous Positive Airway Pressure | 55 | 2024 | 581 | 5.000 |
Why?
|
Pharynx | 53 | 2022 | 436 | 4.490 |
Why?
|
Pharyngeal Muscles | 29 | 2023 | 81 | 4.470 |
Why?
|
Polysomnography | 87 | 2024 | 1868 | 4.110 |
Why?
|
Sleep Apnea Syndromes | 44 | 2024 | 982 | 3.220 |
Why?
|
Respiration | 51 | 2022 | 1654 | 3.060 |
Why?
|
Respiratory Muscles | 27 | 2013 | 144 | 3.020 |
Why?
|
Respiratory Mechanics | 31 | 2014 | 719 | 2.850 |
Why?
|
Airway Resistance | 42 | 2024 | 407 | 2.720 |
Why?
|
Sleep | 78 | 2023 | 4815 | 2.620 |
Why?
|
Sleep Stages | 40 | 2021 | 705 | 2.400 |
Why?
|
Arousal | 29 | 2023 | 1174 | 2.220 |
Why?
|
Tongue | 31 | 2023 | 406 | 2.150 |
Why?
|
Wakefulness | 40 | 2023 | 1282 | 1.960 |
Why?
|
Sleep, REM | 24 | 2022 | 593 | 1.780 |
Why?
|
Electromyography | 68 | 2023 | 1398 | 1.720 |
Why?
|
Mandibular Advancement | 6 | 2022 | 64 | 1.640 |
Why?
|
Pulmonary Ventilation | 20 | 2014 | 375 | 1.460 |
Why?
|
Positive-Pressure Respiration | 11 | 2009 | 712 | 1.380 |
Why?
|
Facial Muscles | 6 | 2022 | 159 | 1.060 |
Why?
|
Hypercapnia | 15 | 2016 | 259 | 0.990 |
Why?
|
Respiratory Physiological Phenomena | 12 | 2013 | 191 | 0.980 |
Why?
|
Carbon Dioxide | 15 | 2010 | 1138 | 0.950 |
Why?
|
Automobile Driving | 3 | 2013 | 442 | 0.900 |
Why?
|
Pressure | 28 | 2019 | 1172 | 0.880 |
Why?
|
Epiglottis | 11 | 2022 | 81 | 0.820 |
Why?
|
Reflex | 13 | 2011 | 375 | 0.790 |
Why?
|
Hypoglossal Nerve | 8 | 2014 | 110 | 0.770 |
Why?
|
Signal Processing, Computer-Assisted | 6 | 2010 | 1457 | 0.760 |
Why?
|
Airway Obstruction | 11 | 2022 | 672 | 0.750 |
Why?
|
Motor Neurons | 13 | 2012 | 869 | 0.740 |
Why?
|
Diagnosis, Computer-Assisted | 4 | 2013 | 698 | 0.730 |
Why?
|
Lung Volume Measurements | 12 | 2012 | 381 | 0.700 |
Why?
|
Muscle Contraction | 8 | 2018 | 1208 | 0.670 |
Why?
|
Hypnotics and Sedatives | 8 | 2021 | 1193 | 0.640 |
Why?
|
Ventilators, Negative-Pressure | 8 | 2011 | 13 | 0.640 |
Why?
|
Sleep Apnea, Central | 6 | 2014 | 88 | 0.600 |
Why?
|
Home Care Services | 3 | 2013 | 659 | 0.550 |
Why?
|
Male | 202 | 2024 | 364142 | 0.540 |
Why?
|
Oxygen Inhalation Therapy | 5 | 2018 | 418 | 0.530 |
Why?
|
Adult | 161 | 2024 | 223307 | 0.530 |
Why?
|
Bariatric Surgery | 2 | 2024 | 996 | 0.530 |
Why?
|
Trazodone | 2 | 2014 | 67 | 0.530 |
Why?
|
Humans | 258 | 2024 | 766766 | 0.490 |
Why?
|
Palatal Muscles | 5 | 2003 | 15 | 0.490 |
Why?
|
Middle Aged | 137 | 2024 | 223257 | 0.480 |
Why?
|
Monitoring, Ambulatory | 3 | 2011 | 357 | 0.470 |
Why?
|
Respiratory Function Tests | 8 | 2014 | 1691 | 0.450 |
Why?
|
Losartan | 1 | 2016 | 263 | 0.450 |
Why?
|
Acoustic Stimulation | 1 | 2018 | 1253 | 0.440 |
Why?
|
Models, Biological | 10 | 2015 | 9461 | 0.430 |
Why?
|
Obesity | 15 | 2024 | 13090 | 0.420 |
Why?
|
G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2013 | 62 | 0.420 |
Why?
|
Female | 156 | 2024 | 396520 | 0.420 |
Why?
|
Muscles | 6 | 2016 | 1576 | 0.420 |
Why?
|
Manometry | 2 | 2006 | 458 | 0.420 |
Why?
|
Inhalation | 7 | 2017 | 142 | 0.420 |
Why?
|
Weight Loss | 1 | 2024 | 2712 | 0.410 |
Why?
|
Quality of Life | 7 | 2017 | 13476 | 0.410 |
Why?
|
Osteoporotic Fractures | 3 | 2023 | 415 | 0.410 |
Why?
|
Muscle, Skeletal | 10 | 2017 | 4970 | 0.410 |
Why?
|
Sex Characteristics | 6 | 2005 | 2645 | 0.410 |
Why?
|
Desipramine | 3 | 2017 | 182 | 0.400 |
Why?
|
Hot Flashes | 5 | 2016 | 329 | 0.390 |
Why?
|
Heart Rate | 11 | 2021 | 4207 | 0.390 |
Why?
|
Mouth Breathing | 6 | 2024 | 25 | 0.380 |
Why?
|
Pharyngeal Diseases | 3 | 2018 | 134 | 0.380 |
Why?
|
Posture | 4 | 2020 | 955 | 0.380 |
Why?
|
Palate, Soft | 5 | 2018 | 100 | 0.370 |
Why?
|
Electroencephalography | 16 | 2018 | 6282 | 0.370 |
Why?
|
Oxygen | 15 | 2022 | 4251 | 0.370 |
Why?
|
Palate | 5 | 2022 | 126 | 0.370 |
Why?
|
Respiratory System | 9 | 2018 | 562 | 0.360 |
Why?
|
Muscle Hypotonia | 2 | 2022 | 166 | 0.350 |
Why?
|
Oropharynx | 3 | 2022 | 139 | 0.330 |
Why?
|
Altitude | 2 | 2010 | 163 | 0.330 |
Why?
|
Mandelic Acids | 2 | 2020 | 46 | 0.330 |
Why?
|
Patient Compliance | 5 | 2016 | 2694 | 0.330 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2015 | 3246 | 0.320 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2016 | 1065 | 0.320 |
Why?
|
Mechanoreceptors | 5 | 2010 | 194 | 0.310 |
Why?
|
Vital Signs | 1 | 2010 | 144 | 0.310 |
Why?
|
Electric Stimulation Therapy | 1 | 2014 | 635 | 0.310 |
Why?
|
Nasal Cavity | 6 | 2009 | 310 | 0.300 |
Why?
|
Wrist | 3 | 2004 | 230 | 0.300 |
Why?
|
Patient Admission | 1 | 2015 | 1364 | 0.290 |
Why?
|
Electrocardiography | 6 | 2018 | 6408 | 0.290 |
Why?
|
Automation | 1 | 2010 | 586 | 0.280 |
Why?
|
Diaphragm | 6 | 2022 | 357 | 0.280 |
Why?
|
Specialization | 2 | 2005 | 779 | 0.270 |
Why?
|
Cross-Over Studies | 10 | 2020 | 2108 | 0.270 |
Why?
|
Blood Pressure | 4 | 2016 | 8533 | 0.270 |
Why?
|
Severity of Illness Index | 16 | 2019 | 15908 | 0.270 |
Why?
|
Equipment Design | 7 | 2014 | 3487 | 0.260 |
Why?
|
Lung | 6 | 2018 | 10067 | 0.260 |
Why?
|
Air Pressure | 6 | 2012 | 75 | 0.250 |
Why?
|
Oximetry | 8 | 2020 | 461 | 0.250 |
Why?
|
Adrenergic Uptake Inhibitors | 4 | 2020 | 186 | 0.250 |
Why?
|
Chemoreceptor Cells | 3 | 2010 | 87 | 0.250 |
Why?
|
Coronary Artery Disease | 3 | 2022 | 6558 | 0.240 |
Why?
|
Endoscopy | 9 | 2024 | 1854 | 0.240 |
Why?
|
Vasoconstriction | 1 | 2008 | 592 | 0.240 |
Why?
|
Gagging | 1 | 2004 | 4 | 0.240 |
Why?
|
Apnea | 5 | 2016 | 193 | 0.240 |
Why?
|
Phrenic Nerve | 4 | 2007 | 81 | 0.240 |
Why?
|
Body Mass Index | 21 | 2021 | 13050 | 0.240 |
Why?
|
Hypocapnia | 3 | 2017 | 38 | 0.240 |
Why?
|
Aging | 6 | 2018 | 8731 | 0.230 |
Why?
|
Reference Values | 9 | 2010 | 4913 | 0.230 |
Why?
|
History of Medicine | 1 | 2005 | 42 | 0.230 |
Why?
|
Disease Management | 2 | 2013 | 2533 | 0.230 |
Why?
|
Feedback, Physiological | 1 | 2007 | 481 | 0.230 |
Why?
|
Exhalation | 5 | 2018 | 185 | 0.230 |
Why?
|
Acetazolamide | 3 | 2014 | 98 | 0.220 |
Why?
|
Case-Control Studies | 19 | 2022 | 22248 | 0.220 |
Why?
|
Aged | 49 | 2023 | 171343 | 0.220 |
Why?
|
Tidal Volume | 8 | 2017 | 519 | 0.220 |
Why?
|
Algorithms | 8 | 2024 | 14072 | 0.220 |
Why?
|
Cardiovascular Diseases | 9 | 2023 | 15657 | 0.220 |
Why?
|
Sleep Initiation and Maintenance Disorders | 5 | 2016 | 1104 | 0.220 |
Why?
|
Long-Term Potentiation | 4 | 2007 | 289 | 0.210 |
Why?
|
Vascular Resistance | 1 | 2006 | 939 | 0.210 |
Why?
|
Anesthesia, Local | 3 | 2000 | 277 | 0.210 |
Why?
|
Sensitivity and Specificity | 11 | 2018 | 14652 | 0.210 |
Why?
|
Atherosclerosis | 3 | 2023 | 3420 | 0.210 |
Why?
|
Parasympatholytics | 2 | 2020 | 89 | 0.200 |
Why?
|
Sleep Disorders, Circadian Rhythm | 1 | 2004 | 197 | 0.200 |
Why?
|
Carbonic Anhydrase Inhibitors | 2 | 2013 | 92 | 0.200 |
Why?
|
Hypertension | 4 | 2023 | 8616 | 0.190 |
Why?
|
Electrooculography | 7 | 2018 | 112 | 0.190 |
Why?
|
Tachycardia | 2 | 2014 | 598 | 0.190 |
Why?
|
Laboratories | 1 | 2005 | 463 | 0.180 |
Why?
|
Patient Readmission | 1 | 2015 | 3283 | 0.180 |
Why?
|
Pulmonary Medicine | 1 | 2003 | 223 | 0.180 |
Why?
|
Equipment and Supplies | 1 | 2003 | 273 | 0.180 |
Why?
|
Cholinergic Agonists | 1 | 2000 | 75 | 0.170 |
Why?
|
Health Care Costs | 1 | 2013 | 3242 | 0.170 |
Why?
|
Lung Compliance | 2 | 2018 | 207 | 0.170 |
Why?
|
Shock | 1 | 2022 | 316 | 0.170 |
Why?
|
Treatment Outcome | 20 | 2024 | 65273 | 0.170 |
Why?
|
Blood Circulation | 1 | 2020 | 248 | 0.170 |
Why?
|
Snoring | 6 | 2024 | 210 | 0.170 |
Why?
|
Cotinine | 1 | 2000 | 206 | 0.160 |
Why?
|
Brain Waves | 2 | 2014 | 416 | 0.160 |
Why?
|
Muscle, Smooth | 3 | 2014 | 931 | 0.160 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 2016 | 1142 | 0.160 |
Why?
|
Expiratory Reserve Volume | 2 | 2009 | 9 | 0.160 |
Why?
|
Functional Residual Capacity | 4 | 2008 | 70 | 0.160 |
Why?
|
Disorders of Excessive Somnolence | 1 | 2022 | 278 | 0.160 |
Why?
|
Estradiol | 3 | 2016 | 1947 | 0.150 |
Why?
|
Feedback | 4 | 2008 | 797 | 0.150 |
Why?
|
Basal Metabolism | 2 | 2017 | 163 | 0.150 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2002 | 881 | 0.150 |
Why?
|
Cheyne-Stokes Respiration | 2 | 2008 | 38 | 0.150 |
Why?
|
Nicotinic Agonists | 1 | 2000 | 265 | 0.150 |
Why?
|
Finite Element Analysis | 3 | 2005 | 441 | 0.150 |
Why?
|
Adaptation, Physiological | 1 | 2004 | 1313 | 0.150 |
Why?
|
4-Aminopyridine | 1 | 2017 | 77 | 0.140 |
Why?
|
Menopause | 3 | 2016 | 1657 | 0.140 |
Why?
|
Oxygen Consumption | 5 | 2017 | 1874 | 0.140 |
Why?
|
Nipecotic Acids | 1 | 2017 | 36 | 0.140 |
Why?
|
Orthodontic Appliances | 1 | 2016 | 40 | 0.140 |
Why?
|
Lidocaine | 5 | 2014 | 545 | 0.140 |
Why?
|
Potassium Channel Blockers | 1 | 2017 | 162 | 0.140 |
Why?
|
Estrogen Replacement Therapy | 1 | 2003 | 1205 | 0.130 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2001 | 391 | 0.130 |
Why?
|
Postmenopause | 2 | 2003 | 2517 | 0.130 |
Why?
|
Propofol | 3 | 2015 | 608 | 0.130 |
Why?
|
Telemedicine | 1 | 2013 | 3111 | 0.130 |
Why?
|
ROC Curve | 4 | 2018 | 3620 | 0.120 |
Why?
|
Computers | 1 | 1998 | 589 | 0.120 |
Why?
|
Risk Assessment | 5 | 2023 | 24295 | 0.120 |
Why?
|
Nicotine | 1 | 2000 | 680 | 0.120 |
Why?
|
Nocturnal Myoclonus Syndrome | 2 | 2006 | 52 | 0.120 |
Why?
|
Respiration, Artificial | 3 | 2011 | 2727 | 0.120 |
Why?
|
Young Adult | 21 | 2019 | 59939 | 0.120 |
Why?
|
Oxyhemoglobins | 2 | 2006 | 213 | 0.120 |
Why?
|
Analgesics, Opioid | 2 | 2016 | 3837 | 0.120 |
Why?
|
Menstrual Cycle | 1 | 1998 | 539 | 0.120 |
Why?
|
Masks | 2 | 2013 | 212 | 0.110 |
Why?
|
Sleep Deprivation | 3 | 2008 | 848 | 0.110 |
Why?
|
Deep Sedation | 1 | 2015 | 119 | 0.110 |
Why?
|
Oscillometry | 2 | 2014 | 151 | 0.110 |
Why?
|
Recruitment, Neurophysiological | 2 | 2010 | 35 | 0.110 |
Why?
|
Hormones | 1 | 1998 | 866 | 0.110 |
Why?
|
Phenotype | 7 | 2018 | 16724 | 0.110 |
Why?
|
Monitoring, Physiologic | 4 | 2014 | 1794 | 0.110 |
Why?
|
Neural Inhibition | 2 | 2010 | 589 | 0.110 |
Why?
|
Serotonin | 2 | 2004 | 1045 | 0.100 |
Why?
|
Receptors, Serotonin | 2 | 2004 | 210 | 0.100 |
Why?
|
Linear Models | 5 | 2014 | 5874 | 0.100 |
Why?
|
Drug Combinations | 1 | 2019 | 2085 | 0.100 |
Why?
|
Nose | 4 | 2000 | 522 | 0.100 |
Why?
|
Trachea | 2 | 2012 | 1094 | 0.100 |
Why?
|
Single-Blind Method | 5 | 2018 | 1587 | 0.100 |
Why?
|
Supine Position | 4 | 2016 | 208 | 0.100 |
Why?
|
Restless Legs Syndrome | 2 | 2005 | 235 | 0.100 |
Why?
|
Double-Blind Method | 9 | 2020 | 12430 | 0.100 |
Why?
|
Anesthetics, Local | 4 | 2014 | 1005 | 0.100 |
Why?
|
Airway Management | 1 | 2015 | 325 | 0.100 |
Why?
|
Reticular Formation | 1 | 1991 | 60 | 0.100 |
Why?
|
Markov Chains | 2 | 2013 | 974 | 0.100 |
Why?
|
Helium | 2 | 2002 | 119 | 0.090 |
Why?
|
Periodicity | 2 | 2003 | 347 | 0.090 |
Why?
|
Time Factors | 16 | 2020 | 40149 | 0.090 |
Why?
|
Analysis of Variance | 3 | 2006 | 6214 | 0.090 |
Why?
|
Prospective Studies | 14 | 2022 | 54871 | 0.090 |
Why?
|
Azabicyclo Compounds | 1 | 2011 | 66 | 0.090 |
Why?
|
Action Potentials | 6 | 2011 | 1835 | 0.090 |
Why?
|
Vagus Nerve | 2 | 2004 | 458 | 0.090 |
Why?
|
Pulmonary Atelectasis | 1 | 2012 | 160 | 0.090 |
Why?
|
Sleep Phase Chronotherapy | 1 | 2010 | 4 | 0.090 |
Why?
|
Conscious Sedation | 1 | 2015 | 534 | 0.090 |
Why?
|
Pulmonary Gas Exchange | 2 | 1990 | 389 | 0.090 |
Why?
|
Kinesthesis | 1 | 2010 | 22 | 0.090 |
Why?
|
Cohort Studies | 11 | 2023 | 41710 | 0.090 |
Why?
|
Seizures | 2 | 2014 | 2996 | 0.090 |
Why?
|
Work of Breathing | 1 | 1990 | 57 | 0.090 |
Why?
|
Airway Remodeling | 1 | 2011 | 134 | 0.090 |
Why?
|
Postoperative Care | 1 | 2016 | 1480 | 0.090 |
Why?
|
Genes, MHC Class I | 1 | 2010 | 236 | 0.090 |
Why?
|
Peak Expiratory Flow Rate | 2 | 2018 | 143 | 0.080 |
Why?
|
Reproducibility of Results | 8 | 2018 | 20144 | 0.080 |
Why?
|
Perimenopause | 1 | 2011 | 142 | 0.080 |
Why?
|
Police | 1 | 2011 | 158 | 0.080 |
Why?
|
Sensory Thresholds | 1 | 2011 | 377 | 0.080 |
Why?
|
Medicine | 1 | 1998 | 944 | 0.080 |
Why?
|
Testosterone | 3 | 2001 | 2495 | 0.080 |
Why?
|
Leptin | 2 | 2010 | 1596 | 0.080 |
Why?
|
HLA-B Antigens | 1 | 2010 | 330 | 0.080 |
Why?
|
Perioperative Care | 1 | 2017 | 1043 | 0.080 |
Why?
|
Research Design | 1 | 2005 | 6207 | 0.080 |
Why?
|
Receptor, Adenosine A1 | 1 | 2008 | 42 | 0.080 |
Why?
|
Plethysmography | 3 | 2014 | 172 | 0.080 |
Why?
|
Quality-Adjusted Life Years | 2 | 2013 | 1740 | 0.080 |
Why?
|
Rats | 11 | 2009 | 23717 | 0.080 |
Why?
|
Asthma | 3 | 1993 | 6268 | 0.080 |
Why?
|
Vestibule, Labyrinth | 1 | 2010 | 235 | 0.080 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2010 | 169 | 0.080 |
Why?
|
Risk Factors | 13 | 2020 | 74881 | 0.070 |
Why?
|
Cost Savings | 1 | 2013 | 902 | 0.070 |
Why?
|
Respiratory Insufficiency | 1 | 2016 | 1241 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5887 | 0.070 |
Why?
|
Patient Selection | 2 | 2014 | 4252 | 0.070 |
Why?
|
Neostigmine | 1 | 2007 | 68 | 0.070 |
Why?
|
Acetylcholinesterase | 1 | 2007 | 151 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 10 | 2008 | 8106 | 0.070 |
Why?
|
History, 20th Century | 2 | 2006 | 2764 | 0.070 |
Why?
|
Homocysteine | 1 | 2010 | 638 | 0.070 |
Why?
|
Safety | 1 | 2011 | 1157 | 0.070 |
Why?
|
Acclimatization | 1 | 1987 | 113 | 0.070 |
Why?
|
Hydromorphone | 1 | 1987 | 70 | 0.070 |
Why?
|
Physiology | 1 | 2007 | 112 | 0.070 |
Why?
|
Prognosis | 3 | 2021 | 29948 | 0.070 |
Why?
|
Autonomic Nervous System | 1 | 2011 | 707 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2017 | 1292 | 0.060 |
Why?
|
Behavior Control | 1 | 2006 | 46 | 0.060 |
Why?
|
Cholinesterase Inhibitors | 1 | 2007 | 242 | 0.060 |
Why?
|
Evaluation Studies as Topic | 2 | 1998 | 1622 | 0.060 |
Why?
|
Animals | 18 | 2013 | 168930 | 0.060 |
Why?
|
Equipment Failure | 1 | 2008 | 585 | 0.060 |
Why?
|
Neurogenesis | 1 | 2011 | 862 | 0.060 |
Why?
|
Antigen Presentation | 1 | 2010 | 1250 | 0.060 |
Why?
|
Anthropometry | 3 | 2016 | 1336 | 0.060 |
Why?
|
Isoflurane | 1 | 2008 | 383 | 0.060 |
Why?
|
Nasal Obstruction | 1 | 2007 | 162 | 0.060 |
Why?
|
Heart Failure | 3 | 2020 | 11882 | 0.060 |
Why?
|
Video Recording | 1 | 2010 | 976 | 0.060 |
Why?
|
Leuprolide | 2 | 2016 | 310 | 0.060 |
Why?
|
Adolescent | 13 | 2016 | 88904 | 0.060 |
Why?
|
Depression | 3 | 2016 | 8228 | 0.060 |
Why?
|
Disulfiram | 1 | 2004 | 63 | 0.060 |
Why?
|
Chronobiology Disorders | 1 | 2005 | 73 | 0.060 |
Why?
|
Menstruation | 2 | 1983 | 310 | 0.060 |
Why?
|
Israel | 1 | 2006 | 726 | 0.060 |
Why?
|
Metabolism | 1 | 1985 | 193 | 0.060 |
Why?
|
Sex Factors | 7 | 2008 | 10619 | 0.060 |
Why?
|
Licensure | 1 | 2005 | 128 | 0.060 |
Why?
|
Executive Function | 1 | 2012 | 1396 | 0.060 |
Why?
|
Mouth | 2 | 2022 | 383 | 0.060 |
Why?
|
Women's Health | 1 | 2013 | 2081 | 0.050 |
Why?
|
Bradycardia | 2 | 2002 | 304 | 0.050 |
Why?
|
Respiration Disorders | 1 | 1987 | 364 | 0.050 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2005 | 111 | 0.050 |
Why?
|
Oral Surgical Procedures | 1 | 2005 | 172 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 2 | 2010 | 2258 | 0.050 |
Why?
|
Encephalomyelitis, Equine | 1 | 1983 | 13 | 0.050 |
Why?
|
Affect | 1 | 2011 | 1494 | 0.050 |
Why?
|
Overweight | 1 | 2014 | 2446 | 0.050 |
Why?
|
Likelihood Functions | 1 | 2006 | 993 | 0.050 |
Why?
|
Neural Pathways | 2 | 2011 | 3079 | 0.050 |
Why?
|
Elasticity | 1 | 2005 | 654 | 0.050 |
Why?
|
Observer Variation | 2 | 2010 | 2614 | 0.050 |
Why?
|
United States | 9 | 2020 | 72951 | 0.050 |
Why?
|
Cats | 2 | 1996 | 972 | 0.050 |
Why?
|
Hypogonadism | 2 | 1986 | 802 | 0.050 |
Why?
|
Occlusal Splints | 1 | 2022 | 18 | 0.050 |
Why?
|
Muscle Tonus | 2 | 2009 | 82 | 0.050 |
Why?
|
Hyperoxia | 2 | 2014 | 259 | 0.050 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2006 | 325 | 0.050 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2008 | 1241 | 0.050 |
Why?
|
Education | 1 | 2005 | 531 | 0.050 |
Why?
|
Sound | 1 | 2024 | 257 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2010 | 5306 | 0.050 |
Why?
|
Air | 1 | 2002 | 182 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2010 | 1217 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 1 | 2002 | 18075 | 0.040 |
Why?
|
Body Constitution | 1 | 2001 | 273 | 0.040 |
Why?
|
Breath Tests | 1 | 2002 | 297 | 0.040 |
Why?
|
Pilot Projects | 3 | 2022 | 8728 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2014 | 3230 | 0.040 |
Why?
|
Piperazines | 1 | 2011 | 2547 | 0.040 |
Why?
|
Rotation | 1 | 2022 | 514 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2023 | 371 | 0.040 |
Why?
|
Electrophysiology | 1 | 2003 | 1263 | 0.040 |
Why?
|
Leg | 1 | 2005 | 1087 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2010 | 3227 | 0.040 |
Why?
|
Dehydroepiandrosterone Sulfate | 1 | 2001 | 240 | 0.040 |
Why?
|
Metals | 1 | 2004 | 712 | 0.040 |
Why?
|
Stress, Mechanical | 1 | 2005 | 1674 | 0.040 |
Why?
|
Bronchi | 1 | 2004 | 847 | 0.040 |
Why?
|
Cardiac Output | 1 | 2002 | 838 | 0.040 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 903 | 0.040 |
Why?
|
Patient Positioning | 1 | 2022 | 332 | 0.040 |
Why?
|
Computer Simulation | 3 | 2014 | 6259 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15416 | 0.040 |
Why?
|
Alpha Rhythm | 1 | 1999 | 107 | 0.040 |
Why?
|
Insulin Resistance | 2 | 2010 | 3989 | 0.040 |
Why?
|
Homeostasis | 1 | 2010 | 3342 | 0.040 |
Why?
|
Electrodes, Implanted | 3 | 2010 | 835 | 0.040 |
Why?
|
Forced Expiratory Volume | 3 | 1991 | 1828 | 0.040 |
Why?
|
History, 21st Century | 1 | 2005 | 1574 | 0.040 |
Why?
|
Health Status | 1 | 2011 | 4087 | 0.040 |
Why?
|
Motor Activity | 2 | 2008 | 2711 | 0.040 |
Why?
|
Anesthesia | 3 | 2017 | 1595 | 0.040 |
Why?
|
Movement | 1 | 2005 | 1468 | 0.040 |
Why?
|
C-Reactive Protein | 1 | 2010 | 3853 | 0.040 |
Why?
|
Prolapse | 1 | 2018 | 63 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2004 | 2351 | 0.040 |
Why?
|
Circadian Rhythm | 2 | 2013 | 2593 | 0.040 |
Why?
|
Follicle Stimulating Hormone | 2 | 2011 | 731 | 0.040 |
Why?
|
Progesterone | 2 | 1998 | 752 | 0.040 |
Why?
|
Inspiratory Capacity | 1 | 2017 | 35 | 0.040 |
Why?
|
Theta Rhythm | 1 | 1999 | 220 | 0.040 |
Why?
|
Dopamine | 1 | 2005 | 1581 | 0.040 |
Why?
|
Follicular Phase | 1 | 1998 | 143 | 0.040 |
Why?
|
Luteal Phase | 1 | 1998 | 138 | 0.040 |
Why?
|
Eyelids | 1 | 1999 | 278 | 0.040 |
Why?
|
Hospitalization | 2 | 2016 | 10823 | 0.030 |
Why?
|
Spinal Cord | 1 | 2005 | 1811 | 0.030 |
Why?
|
Blood Gas Monitoring, Transcutaneous | 1 | 2016 | 34 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2022 | 12064 | 0.030 |
Why?
|
Coronary Disease | 2 | 2003 | 5915 | 0.030 |
Why?
|
Respiratory Mucosa | 1 | 2000 | 437 | 0.030 |
Why?
|
Mucous Membrane | 1 | 2000 | 658 | 0.030 |
Why?
|
Decerebrate State | 1 | 1996 | 42 | 0.030 |
Why?
|
Logistic Models | 3 | 2018 | 13278 | 0.030 |
Why?
|
Antidepressive Agents | 2 | 2006 | 2903 | 0.030 |
Why?
|
Research | 1 | 2005 | 1977 | 0.030 |
Why?
|
Respiratory Rate | 1 | 2017 | 179 | 0.030 |
Why?
|
Head | 1 | 2022 | 926 | 0.030 |
Why?
|
Fertility Agents, Female | 1 | 2016 | 101 | 0.030 |
Why?
|
Muscle Relaxation | 1 | 1996 | 138 | 0.030 |
Why?
|
Weight Gain | 1 | 2006 | 2356 | 0.030 |
Why?
|
Tracheostomy | 1 | 2000 | 430 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1754 | 0.030 |
Why?
|
Databases, Factual | 1 | 2011 | 8066 | 0.030 |
Why?
|
Microinjections | 1 | 1996 | 319 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8540 | 0.030 |
Why?
|
Neuronal Plasticity | 1 | 2004 | 1446 | 0.030 |
Why?
|
Nasopharynx | 1 | 1998 | 419 | 0.030 |
Why?
|
Child | 5 | 2013 | 80668 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2016 | 418 | 0.030 |
Why?
|
Vital Capacity | 3 | 1991 | 995 | 0.030 |
Why?
|
Regression Analysis | 2 | 2017 | 6329 | 0.030 |
Why?
|
Placebo Effect | 1 | 2019 | 515 | 0.030 |
Why?
|
Cognition | 1 | 2012 | 7057 | 0.030 |
Why?
|
Differential Threshold | 1 | 2014 | 80 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2008 | 10745 | 0.030 |
Why?
|
Chronic Disease | 3 | 2004 | 9357 | 0.030 |
Why?
|
Benchmarking | 1 | 2021 | 1056 | 0.030 |
Why?
|
Disease Progression | 3 | 2010 | 13640 | 0.030 |
Why?
|
Ketanserin | 2 | 2004 | 24 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2023 | 59550 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15831 | 0.030 |
Why?
|
Military Personnel | 1 | 2003 | 1260 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 6 | 2007 | 36567 | 0.030 |
Why?
|
Hyperventilation | 1 | 2014 | 78 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2007 | 4047 | 0.030 |
Why?
|
Intercostal Muscles | 1 | 1993 | 26 | 0.030 |
Why?
|
Lung Diseases, Obstructive | 2 | 1987 | 309 | 0.030 |
Why?
|
HIV-1 | 1 | 2010 | 6948 | 0.030 |
Why?
|
Prevalence | 3 | 2006 | 15835 | 0.030 |
Why?
|
Neck Muscles | 1 | 1993 | 100 | 0.030 |
Why?
|
Forecasting | 2 | 2001 | 2936 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2846 | 0.030 |
Why?
|
Body Temperature | 2 | 2008 | 780 | 0.030 |
Why?
|
Body Weight | 1 | 2003 | 4626 | 0.020 |
Why?
|
Premenopause | 1 | 2016 | 1039 | 0.020 |
Why?
|
Bethanechol Compounds | 1 | 1991 | 10 | 0.020 |
Why?
|
Bethanechol | 1 | 1991 | 12 | 0.020 |
Why?
|
Atmospheric Pressure | 1 | 1991 | 48 | 0.020 |
Why?
|
Death, Sudden | 1 | 2013 | 301 | 0.020 |
Why?
|
Galvanic Skin Response | 1 | 2013 | 359 | 0.020 |
Why?
|
Bronchoscopy | 1 | 2017 | 913 | 0.020 |
Why?
|
Carbachol | 1 | 1991 | 223 | 0.020 |
Why?
|
Follow-Up Studies | 5 | 2016 | 39309 | 0.020 |
Why?
|
Age Factors | 4 | 2013 | 18397 | 0.020 |
Why?
|
Methods | 1 | 1991 | 1065 | 0.020 |
Why?
|
Estrogens | 1 | 1998 | 1528 | 0.020 |
Why?
|
Aftercare | 1 | 2017 | 915 | 0.020 |
Why?
|
Plethysmography, Whole Body | 1 | 1990 | 25 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2008 | 7431 | 0.020 |
Why?
|
Comorbidity | 3 | 2011 | 10580 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2006 | 12985 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 2010 | 146 | 0.020 |
Why?
|
Pons | 1 | 1991 | 239 | 0.020 |
Why?
|
Mass Screening | 1 | 2006 | 5454 | 0.020 |
Why?
|
Clozapine | 2 | 2004 | 509 | 0.020 |
Why?
|
HLA-A Antigens | 1 | 2010 | 223 | 0.020 |
Why?
|
HIV Long-Term Survivors | 1 | 2010 | 140 | 0.020 |
Why?
|
Data Interpretation, Statistical | 2 | 2012 | 2693 | 0.020 |
Why?
|
Odds Ratio | 2 | 2015 | 9661 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8507 | 0.020 |
Why?
|
HIV Antigens | 1 | 2010 | 328 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2004 | 10384 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6307 | 0.020 |
Why?
|
Cephalometry | 1 | 1991 | 380 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 2016 | 1479 | 0.020 |
Why?
|
Ventilation-Perfusion Ratio | 2 | 1987 | 115 | 0.020 |
Why?
|
Cross-Sectional Studies | 5 | 2011 | 26310 | 0.020 |
Why?
|
Incidence | 3 | 2020 | 21525 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 2013 | 966 | 0.020 |
Why?
|
Health Planning Councils | 1 | 2008 | 11 | 0.020 |
Why?
|
Professional Staff Committees | 1 | 2008 | 37 | 0.020 |
Why?
|
Administration, Cutaneous | 1 | 2011 | 712 | 0.020 |
Why?
|
Voluntary Health Agencies | 1 | 2008 | 38 | 0.020 |
Why?
|
Electric Stimulation | 2 | 2004 | 1736 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2003 | 4554 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2004 | 5753 | 0.020 |
Why?
|
North America | 1 | 2011 | 1287 | 0.020 |
Why?
|
Vecuronium Bromide | 1 | 2007 | 33 | 0.020 |
Why?
|
Glycopyrrolate | 1 | 2007 | 35 | 0.020 |
Why?
|
Corticosterone | 1 | 2008 | 301 | 0.020 |
Why?
|
Task Performance and Analysis | 1 | 2011 | 771 | 0.020 |
Why?
|
Partial Pressure | 1 | 1987 | 247 | 0.020 |
Why?
|
Atropine | 1 | 2007 | 243 | 0.020 |
Why?
|
Actigraphy | 1 | 2011 | 526 | 0.020 |
Why?
|
Fluoroscopy | 1 | 1991 | 948 | 0.020 |
Why?
|
Muscimol | 1 | 2006 | 70 | 0.020 |
Why?
|
Reaction Time | 1 | 1993 | 2085 | 0.020 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2008 | 325 | 0.020 |
Why?
|
Kinetics | 1 | 2014 | 6287 | 0.020 |
Why?
|
Muscarinic Antagonists | 1 | 2007 | 135 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2017 | 1921 | 0.020 |
Why?
|
Neuromuscular Nondepolarizing Agents | 1 | 2007 | 145 | 0.020 |
Why?
|
GABA Agonists | 1 | 2006 | 106 | 0.020 |
Why?
|
Neurons | 1 | 2006 | 9515 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2016 | 1768 | 0.020 |
Why?
|
Health Insurance Portability and Accountability Act | 1 | 2006 | 105 | 0.020 |
Why?
|
Risk | 2 | 2011 | 9602 | 0.020 |
Why?
|
Melanoma | 1 | 2004 | 5700 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2000 | 3967 | 0.020 |
Why?
|
Habits | 1 | 2006 | 148 | 0.020 |
Why?
|
Sympathetic Nervous System | 1 | 2008 | 520 | 0.020 |
Why?
|
Rabbits | 1 | 2012 | 4752 | 0.020 |
Why?
|
Evoked Potentials | 1 | 2011 | 1050 | 0.020 |
Why?
|
Occupational Health | 1 | 2011 | 812 | 0.020 |
Why?
|
Dizocilpine Maleate | 1 | 2005 | 171 | 0.020 |
Why?
|
Genital Diseases, Female | 1 | 2006 | 192 | 0.010 |
Why?
|
Administration, Oral | 1 | 2013 | 4018 | 0.010 |
Why?
|
Physical Exertion | 1 | 1987 | 667 | 0.010 |
Why?
|
Transcription Factors | 1 | 2004 | 12150 | 0.010 |
Why?
|
Cyclin A | 1 | 2004 | 59 | 0.010 |
Why?
|
Amino Acids | 1 | 2010 | 1711 | 0.010 |
Why?
|
Haplotypes | 1 | 2010 | 2727 | 0.010 |
Why?
|
Submarine Medicine | 1 | 2003 | 4 | 0.010 |
Why?
|
Methysergide | 1 | 2003 | 28 | 0.010 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2004 | 294 | 0.010 |
Why?
|
HIV Infections | 1 | 2010 | 17536 | 0.010 |
Why?
|
Residual Volume | 1 | 1983 | 40 | 0.010 |
Why?
|
American Heart Association | 1 | 2008 | 1049 | 0.010 |
Why?
|
Quality Control | 1 | 2006 | 834 | 0.010 |
Why?
|
Encephalitis Virus, Western Equine | 1 | 1983 | 7 | 0.010 |
Why?
|
Serotonin Antagonists | 1 | 2003 | 146 | 0.010 |
Why?
|
Drug Therapy | 1 | 2006 | 504 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2011 | 1885 | 0.010 |
Why?
|
Response Elements | 1 | 2004 | 308 | 0.010 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2008 | 856 | 0.010 |
Why?
|
Habituation, Psychophysiologic | 1 | 2003 | 144 | 0.010 |
Why?
|
Memory | 1 | 2012 | 2192 | 0.010 |
Why?
|
Neural Conduction | 1 | 2004 | 442 | 0.010 |
Why?
|
Protein Conformation | 1 | 2010 | 3947 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3561 | 0.010 |
Why?
|
Placebos | 1 | 1987 | 1659 | 0.010 |
Why?
|
Eye Neoplasms | 1 | 2004 | 305 | 0.010 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2003 | 240 | 0.010 |
Why?
|
Copper | 1 | 2004 | 365 | 0.010 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 501 | 0.010 |
Why?
|
Glutathione | 1 | 2004 | 589 | 0.010 |
Why?
|
Models, Animal | 1 | 2008 | 2121 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2004 | 13643 | 0.010 |
Why?
|
Viral Load | 1 | 2010 | 3385 | 0.010 |
Why?
|
Demography | 1 | 2006 | 1641 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2011 | 6020 | 0.010 |
Why?
|
Canada | 1 | 2006 | 2126 | 0.010 |
Why?
|
Models, Molecular | 1 | 2010 | 5386 | 0.010 |
Why?
|
Zinc | 1 | 2004 | 675 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2008 | 1567 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2007 | 1791 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2006 | 3432 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2003 | 1154 | 0.010 |
Why?
|
Prostheses and Implants | 1 | 2007 | 1275 | 0.010 |
Why?
|
Benzodiazepines | 1 | 2006 | 1137 | 0.010 |
Why?
|
Dyspnea | 1 | 1987 | 1352 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6895 | 0.010 |
Why?
|
Ethanol | 1 | 1985 | 1326 | 0.010 |
Why?
|
Mice, SCID | 1 | 2004 | 2628 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 2004 | 1227 | 0.010 |
Why?
|
Bronchitis | 1 | 1980 | 193 | 0.010 |
Why?
|
Pyridines | 1 | 2011 | 2888 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2010 | 3077 | 0.010 |
Why?
|
Epilepsy | 1 | 2014 | 3317 | 0.010 |
Why?
|
Depressive Disorder | 1 | 2011 | 3715 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 2004 | 1175 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 3 | 1991 | 20708 | 0.010 |
Why?
|
Myocardial Ischemia | 1 | 2008 | 2132 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2008 | 2143 | 0.010 |
Why?
|
Hypertension, Pulmonary | 1 | 2008 | 1604 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2008 | 3139 | 0.010 |
Why?
|
Down-Regulation | 1 | 2004 | 2931 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2017 | 81635 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2010 | 4652 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2008 | 4424 | 0.010 |
Why?
|
Air Pollution, Indoor | 1 | 2003 | 931 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2008 | 2505 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2010 | 2662 | 0.010 |
Why?
|
Life Style | 1 | 2006 | 3926 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2004 | 2631 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2006 | 2160 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2006 | 5536 | 0.010 |
Why?
|
Spirometry | 2 | 1987 | 929 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2006 | 7841 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2006 | 12534 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 2006 | 3229 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 12806 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 16044 | 0.010 |
Why?
|
Atrial Fibrillation | 1 | 2008 | 5182 | 0.000 |
Why?
|
Cell Proliferation | 1 | 2004 | 10445 | 0.000 |
Why?
|
Liver Neoplasms | 1 | 2004 | 4353 | 0.000 |
Why?
|
Cell Line, Tumor | 1 | 2004 | 17088 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2006 | 18330 | 0.000 |
Why?
|
Stroke | 1 | 2008 | 9741 | 0.000 |
Why?
|
Colorado | 1 | 1984 | 167 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 2009 | 21162 | 0.000 |
Why?
|
Hyperbaric Oxygenation | 1 | 1982 | 167 | 0.000 |
Why?
|
Pulmonary Alveoli | 1 | 1984 | 665 | 0.000 |
Why?
|
China | 1 | 1984 | 2383 | 0.000 |
Why?
|
Mice | 1 | 2004 | 81889 | 0.000 |
Why?
|